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ABSTRACT 
The article presents the results of the discovery of violation of 
concentration of prostaglandins and endothelial factors in the blood of 
pregnant women with gestational diabetes, depending on the nature of 
the compensation of the disease. 
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Introduction. In the 1960s, the British pathologist of Australian origin Howard Flory, first 
using an electron microscopy, established how macromolecules diffuse through the walls of the 
arteries and veins of various organs. He first discovered the membrane microstructure of endothelium 
and intercellular compounds involved in the transport processes. The works of G. Flory served as the 
basis for today's ideas about endothelium. Endothelial cells form a single layer of cells lining the 
vascular and lymphatic system, which forms the barrier between blood and lymph in vessels and 
surrounding tissues. The total area of the endothelium is over 1000 m2 [1,7,8]. 
Vascular changes that arise in gestational diabetes mellitus are the main cause of 
complications during pregnancy and are directly related to the complications of the fetus. There is no 
doubt that such changes have a polyethiological character and further development of science can 
bring much new in their understanding [2]. 
Diabetic microangiopathy is universal and manifests itself both in the blood vessels of the 
kidneys, retina, and in the vessels of the fetoplacental complex. Defeat of endothelial wall is directly 
related to chronic hyperglycemia, which is realized not as an independent mechanism, but through 
other processes ‒ sorbitol shunt or non-enzyme glycation of proteins, and others. The most harmful 
effects are irreversible end-products of glycation, which alter the structure and metabolism of the main 
proteins of body. When reacting with endothelial cells, they cause damage to them. This leads to an 
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increase in the permeability of the endothelial barrier for low molecular weight substances, as well as 
the ejection of procoagulant factors that provoke thrombotic occlusion of the capillaries and the 
development of coagulopathies [2, 6]. 
The products of irreversible glycation are formed in the body of a patient with diabetes quite 
quickly, within a few months, after which even the most thorough compensation of metabolic 
disorders is no longer able to eliminate the presence of these products. The irreversibility of end-
product of non-enzyme glycation explains the progression of micro- and macrovascular complications, 
even with very good compensation for diabetes [2]. 
Traditionally, endothelial dysfunction is directly associated with imbalance in mediators that 
provide vascular tone regulation: endogenous vascular relaxation factors (NO, natriuretic type C 
peptide) and constriction (endothelin-1, prostaglandin F2α). The study of these indicators can provide 
information on the severity of endothelial dysfunction [1, 4, 7]. 
A large, though very fragmented material has been accumulated on the role of endothelial 
dysfunction in the pathogenesis of vascular complications in diabetes mellitus during pregnancy. At the same 
time, data on the manifestation of this pathology in women with gestational diabetes mellitus is absent. 
Materials and methods.  
To solve the problems, 150 pregnant women with diabetes mellitus were examined and 
examined at the maternity ward for pregnant women with metabolic disorders and fetal malformations 
of the IPAG NAMS Ukraine. 
The control group consisted of patients in whom the gestational diabetes (GD) was not detected; 
their pregnancy went through without complications; severe extragenital pathology was not observed. 
Taking into account the features of therapy for correction of carbohydrate metabolism, 105 
(70.0%) patients were diagnosed with GI class A1, that is, the pathology in which normalization of 
carbohydrate metabolism was achieved only by diet. In 45 (30.0%) women diagnosed with grade A2 DD; 
they used insulin therapy and / or metformin to normalize the carbohydrate metabolism along with the diet. 
The state of the endothelial function was assessed by the prostaglandin E2 (PGE2), 
prostaglandin F2α (PGF2α), prostacyclin (PGI2), thromboxane B2 (TxB2), endothelin-1 (ET-1), nitric 
oxide (NO), L- arginine on the immune enzyme analyzer «Sunrise» of the firm «Tecan». 
Results.  
The main endothelial vasoconstrictors, above all, are endothelin-1. In the study, it was found 
that endothelin-1 indices in women with GCS practically doubled these rates in healthy pregnant 
women (16.4 ± 1.4 and 8.3 ± 1.4 (p <0.001). Comparison of this indicator in groups A1 and A2 
showed that women with GCD, whose compensation was achieved by diet, had no significant 
deviations from the indicator of healthy pregnant women (8.9 ± 1.7 (p> 0.05). At the same time, the 
amount of endothelin-1 significantly increased in women with GCD, whose compensation was 
achieved by insulin (21.8 ± 1.6 (p <0.01). See Table 1. 
Determination of the prostaglandin indexes of different groups in women with GCD showed a 
significant imbalance with a marked prevalence of the effect of prostaglandins on the vasoconstrictor 
effect (FH2 FV - 1.5 times, thromboxane (T × B2) - 1.6 fold) and decreased prostaglandins depressor 
activity (PGE2 in 2.6 times, PGI2 - 1.3 times) compared with healthy pregnant women. Analysis of 
the level of prostaglandins in groups A1 and A2 determined that there was no significant difference in 
the level of prostaglandins in depressor activity. PGE2 was 2.79 ± 0.29 ng / ml and 2.38 ± 0.29 ng / ml 
in groups A1 and A2 (p> 0.05) and PGI2 was 43.6 ± 3.5 pg / ml and 41, 6 ± 3.1 pg / ml, respectively 
(p> 0.05). See Table 1. However, in women, the compensation of HIC that was achieved by insulin 
had a significant increase in prostaglandins vasoconstrictor effect compared with pregnant women at 
GCD, whose compensation was achieved by diet (GH F2α - 0,97 ± 0,06 ng / ml and 0,66 ± 0.05 ng / 
ml respectively (p <0.001). 
Despite the fact that identification of nitric oxide (NO) as a biological agent produced by the 
endothelium to regulate the vascular wall tone occurred 38 years ago, it remains the main factor in 
vascular relaxation. The determination of NO revealed its significant decrease in women of the A2 
group compared with the NO index in healthy pregnant women (2.09 ± 0.12 γ / mol and 3.7 ± 0.4 γ / 
mol respectively (p <0.001). NO indices healthy women and women of the A1 group were similar (3.7 
± 0.4 γ / moll and 3.14 ± 0.13 respectively) (p> 0.05) Similar results were obtained for L-arginine. 
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Table 1. Concentration of prostaglandins and endothelial factors in the blood of pregnant 
women with gestational diabetes, depending on the nature of the compensation of the disease 
Indicator  
Healthy 
Patients with GD 
Р 1-2 Р 1-3 Р 2-3 class А1 class А2 
1st 2nd 3d 
PGЕ2, ng/ml 6,45±0,21 2,79±0,29 2,38±0,29 < 0,001 < 0,001 > 0,05 
PGF2α, ng/ml 0,39±0,05 0,66±0,05 0,97±0,06 < 0,001 < 0,001 < 0,001 
PGF2α/ПГЕ2 0,06 0,24 0,41 - - - 
PGІ2, pg/ml 86,4±8,5 43,6±3,5 41,6±3,1 > 0,05 < 0,001 > 0,05 
ТхВ2, pg/ml 40,5±4,5 74,7±3,9 79,9±4,0 < 0,001 < 0,001 > 0,05 
ТхВ2,/PGІ2 0,47 1,71 1,92 - - - 
Ет-1, pg/ml 8,3±1,3 8,9±1,7 21,8±1,6 > 0,05 < 0,001 < 0,001 
NO, γ/moll 3,7±0,4 3,14±0,13 2,09±0,12 > 0,05 < 0,001 < 0,001 
L-arginin, 
mmoll/l 
50,7±0,4 49,7±1,5 32,4±1,5 > 0,05 < 0,001 < 0,01 
Ет-1-/NO 2,23 3,2 10,4 - - - 
 
Conclusions. Thus, an analysis of endothelial function in comparator groups of women 
allowed us to conclude that the endothelium is a target for gestational diabetes mellitus. The imbalance 
between the substances of pressor and depressor activity with the predominance of the first has a 
reliable association with the type of gestational diabetes mellitus. However, the data obtained are 
mediated. Only further study of the typical complications in comparative groups of women with GD 
can give a true picture of the impact of this pathology on the course of pregnancy. 
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